Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.

Hao, Shuai; Luo, Rongkun; Li, Wei; Zhao, Ruhan; Qi, Tong; Wang, Zichen; Li, Nan; Liu, Ming

Hao, Shuai; Luo, Rongkun; Li, Wei; Zhao, Ruhan; Qi, Tong; Wang, Zichen; Li, Nan; Liu, Ming.

Afiliación

Hao S; Department of Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.
Luo R; Graduate School of Hebei Medical University, Shijiazhuang, Hunan, PR China.
Li W; Department of Hepatobiliary and Pancreatic Surgery, Third Xiangya Hospital, Central South University, Changsha, Hunan, PR China.
Zhao R; Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China.
Qi T; Department of Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.
Wang Z; Department of Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.
Li N; Department of Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.
Liu M; Graduate School of Hebei Medical University, Shijiazhuang, Hunan, PR China.

BMC Gastroenterol ; 23(1): 207, 2023 Jun 13.

Article en En | MEDLINE | ID: mdl-37312022

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Anciano; Pronóstico; Carcinoma Hepatocelular/terapia; alfa-Fetoproteínas; Neoplasias Hepáticas/terapia; Nomogramas

Palabras clave

Hepatocellular carcinoma (HCC); Nomogram; Overall survival(OS); Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: BMC Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google